Cargando…
Cannabinoid WIN55, 212-2 induces cell cycle arrest and inhibits the proliferation and migration of human BEL7402 hepatocellular carcinoma cells
Hepatocellular carcinoma (HCC) is the leading cause of cancer-associated mortality worldwide; however, only limited therapeutic treatments are currently available. The present study aimed to investigate the effects of cannabinoids as novel therapeutic targets in HCC. In addition, the mechanism under...
Autores principales: | XU, DACAI, WANG, JIANGLIN, ZHOU, ZHENKANG, HE, ZHIWEI, ZHAO, QING |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4758282/ https://www.ncbi.nlm.nih.gov/pubmed/26500101 http://dx.doi.org/10.3892/mmr.2015.4477 |
Ejemplares similares
-
Cannabinoid WIN55, 212-2 induces cell cycle arrest and inhibits the proliferation and migration of human BEL7402 hepatocellular carcinoma cells
por: Xu, Dacai, et al.
Publicado: (2016) -
Effects of alpha fetoprotein on escape of Bel 7402 cells from attack of lymphocytes
por: Li, Mengsen, et al.
Publicado: (2005) -
Metformin reverses multidrug resistance in human hepatocellular carcinoma Bel-7402/5-fluorouracil cells
por: LING, SUNBIN, et al.
Publicado: (2014) -
Metformin reverses multidrug resistance in human hepatocellular carcinoma Bel-7402/5-fluorouracil cells
por: Ling, Sunbin, et al.
Publicado: (2022) -
Involvement of the CB(2) cannabinoid receptor in cell growth inhibition and G0/G1 cell cycle arrest via the cannabinoid agonist WIN 55,212–2 in renal cell carcinoma
por: Khan, Mohammed I., et al.
Publicado: (2018)